missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Influenza A H3N2 Virions Polyclonal Antibody, Biotin

Description
The PA1-73049 antibody reacts with Influenza A virions H3N2. PA1-73049 has been successfully used in Immunohistochemical, ELISA, Immunofluorescence and Western blot applications. The PA1-73049 antibody was raised against Influenza A, strain Texas 1/77 (H3N2).
Influenza viruses consists of three types (Influenza A, B, and C), which make up three of the five genera in the Orthomyxoviridae family. Commonly know as the flu, influenza strains can affect both birds and mammals. Influenza strains form roughly spherical particles and are similar in composition with viral envelope containing two main types of glycoproteins (hemagglutinin and neuraminidase), wrapped around the central core of the viral RNA genome and other viral proteins that package and protect the RNA. Unusually for a virus, the influenzavirus genome is not a single piece of nucleic acid; rather a seven to eight segmented fragments of negative-sense RNA with each fragment expressing different viral proteins. Influenza spreads seasonally, resulting in about three to five million yearly cases of severe illness and about 250,000 to 500,000 deaths annually or into the millions in pandemic years.
Specifications
Specifications
| Antigen | Influenza A H3N2 Virions |
| Applications | ELISA, Immunohistochemistry, Western Blot |
| Classification | Polyclonal |
| Concentration | 4-5 mg/mL |
| Conjugate | Biotin |
| Formulation | PBS with 0.1% sodium azide; pH 7.2 |
| Gene Alias | H3N2; H3N2 virions; Influenza H3N2 |
| Host Species | Goat |
| Immunogen | Influenza A, strain Texas 1/77 (H3N2). |
| Purification Method | IgG fraction |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?